https://www.selleckchem.com/pr....oducts/Cyclopamine.h
2% (95% CI 36.5%, 47.2%); whereas, dysgeusia was reported in 11,337 patients out of 30,901 COVID-19 patients from 101 studies, with prevalence of 36.6% (95% CI 35.2%, 45.2%), worldwide. Furthermore, the prevalence of anosmia was 10.2-fold higher (OR 10.21; 95% CI 6.53, 15.96, p less then 0.001) and that of dysgeusia was 8.6-fold higher (OR 8.61; 95% CI 5.26, 14.11, p less then 0.001) in COVID-19 patients compared to those with other respiratory infections or COVID-19 like illness. To date, no study has assessed the association of an
Like
Comment
Share
